QQQ   277.84 (+0.68%)
AAPL   115.81 (+1.51%)
MSFT   210.33 (+1.48%)
FB   261.90 (+0.04%)
GOOGL   1,465.60 (-0.03%)
AMZN   3,148.73 (+0.12%)
TSLA   429.01 (+2.37%)
NVDA   541.22 (+2.30%)
BABA   293.98 (+6.16%)
CGC   14.32 (-1.24%)
MU   46.96 (-7.39%)
GE   6.23 (+1.80%)
AMD   81.99 (+0.27%)
T   28.51 (+0.74%)
F   6.66 (+0.91%)
ACB   4.65 (-0.64%)
GILD   63.19 (+1.76%)
NFLX   500.03 (+1.33%)
DIS   124.08 (-1.05%)
BA   165.26 (+1.01%)
BAC   24.09 (+1.35%)
QQQ   277.84 (+0.68%)
AAPL   115.81 (+1.51%)
MSFT   210.33 (+1.48%)
FB   261.90 (+0.04%)
GOOGL   1,465.60 (-0.03%)
AMZN   3,148.73 (+0.12%)
TSLA   429.01 (+2.37%)
NVDA   541.22 (+2.30%)
BABA   293.98 (+6.16%)
CGC   14.32 (-1.24%)
MU   46.96 (-7.39%)
GE   6.23 (+1.80%)
AMD   81.99 (+0.27%)
T   28.51 (+0.74%)
F   6.66 (+0.91%)
ACB   4.65 (-0.64%)
GILD   63.19 (+1.76%)
NFLX   500.03 (+1.33%)
DIS   124.08 (-1.05%)
BA   165.26 (+1.01%)
BAC   24.09 (+1.35%)
QQQ   277.84 (+0.68%)
AAPL   115.81 (+1.51%)
MSFT   210.33 (+1.48%)
FB   261.90 (+0.04%)
GOOGL   1,465.60 (-0.03%)
AMZN   3,148.73 (+0.12%)
TSLA   429.01 (+2.37%)
NVDA   541.22 (+2.30%)
BABA   293.98 (+6.16%)
CGC   14.32 (-1.24%)
MU   46.96 (-7.39%)
GE   6.23 (+1.80%)
AMD   81.99 (+0.27%)
T   28.51 (+0.74%)
F   6.66 (+0.91%)
ACB   4.65 (-0.64%)
GILD   63.19 (+1.76%)
NFLX   500.03 (+1.33%)
DIS   124.08 (-1.05%)
BA   165.26 (+1.01%)
BAC   24.09 (+1.35%)
QQQ   277.84 (+0.68%)
AAPL   115.81 (+1.51%)
MSFT   210.33 (+1.48%)
FB   261.90 (+0.04%)
GOOGL   1,465.60 (-0.03%)
AMZN   3,148.73 (+0.12%)
TSLA   429.01 (+2.37%)
NVDA   541.22 (+2.30%)
BABA   293.98 (+6.16%)
CGC   14.32 (-1.24%)
MU   46.96 (-7.39%)
GE   6.23 (+1.80%)
AMD   81.99 (+0.27%)
T   28.51 (+0.74%)
F   6.66 (+0.91%)
ACB   4.65 (-0.64%)
GILD   63.19 (+1.76%)
NFLX   500.03 (+1.33%)
DIS   124.08 (-1.05%)
BA   165.26 (+1.01%)
BAC   24.09 (+1.35%)
Log in
OTCMKTS:CRXM

Gene Biotherapeutics Short Interest Ratio and Short Volume

$0.06
-0.01 (-13.79 %)
(As of 09/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.06
Now: $0.06
$0.07
50-Day Range
$0.06
MA: $0.08
$0.10
52-Week Range
$0.02
Now: $0.06
$0.19
Volume687,490 shs
Average Volume181,218 shs
Market Capitalization$905,562.50
P/E RatioN/A
Dividend YieldN/A
Beta1.71

Short Interest

Gene Biotherapeutics (OTCMKTS:CRXM) Short Interest Data

Current Short Volume:25,800 shares
Previous Short Volume:49,600 shares
Change Vs. Previous Month:-47.98%
Dollar Volume Sold Short:$1,806.00
Short Interest Ratio / Days to Cover:0.0
Last Record Date:September, 15 2020
Outstanding Shares:14,489,000 shares
Short Percent of Float:0.00%
Today's Trading Volume:687,490 shares
Average Trading Volume:181,218 shares
Today's Volume Vs. Average:279.37%



Gene Biotherapeutics (OTCMKTS:CRXM) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
9/15/202025,800 $1,806.00 -48.0%0.0%0$0.07
8/31/202049,600 $0.00 49,500.0%0.0%0.1$0.00
8/14/2020100 $0.00 -99.8%0.0%0$0.00
7/31/202062,300 $0.00 74.5%0.0%0.1$0.00
7/15/202035,700 $2,856.00 -40.4%0.0%0$0.08
6/30/202059,900 $5,391.00 57.6%0.0%0.6$0.09
6/15/202038,000 $1,520.00 103.2%0.0%0.2$0.04
5/29/202018,700 $748.00 12.0%0.0%0.4$0.04
5/15/202016,700 $2,505.00 328.2%0.0%1.1$0.15
4/30/20203,900 $546.00 3,800.0%0.0%0.1$0.14
4/15/2020100 $0.00 0.0%0.0%0$0.00
3/31/2020100 $15.00 0.0%0.0%0$0.15
3/13/2020100 $15.00 0.0%0.0%0$0.15
2/28/2020100 $0.00 0.0%0.0%0$0.00
2/14/2020100 $16.00 0.0%0.0%0.1$0.16
1/31/2020100 $16.00 0.0%0.0%0$0.16
1/15/2020100 $17.00 -50.0%0.0%0$0.17
12/31/2019200 $30.00 100.0%0.0%0$0.15

Gene Biotherapeutics (OTCMKTS:CRXM) Short Interest FAQ

speech bubbles
speech bubbles











What is Gene Biotherapeutics' current short interest?

Short interest is the volume of Gene Biotherapeutics shares that have been sold short but have not yet been covered or closed out. As of September 15th, investors have sold 25,800 shares of CRXM short. 0.00% of Gene Biotherapeutics' shares are currently sold short. View details.

Is Gene Biotherapeutics' short interest increasing or decreasing?

Gene Biotherapeutics saw a drop in short interest during the month of September. As of September 15th, there was short interest totaling 25,800 shares, a drop of 48.0% from the previous total of 49,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Gene Biotherapeutics' short interest compare to its competitors?

0.00% of Gene Biotherapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Gene Biotherapeutics: Amgen, Inc. (1.16%), Gilead Sciences, Inc. (1.44%), Biogen Inc (2.33%), Seattle Genetics, Inc. (0.00%), Moderna Inc (8.76%), NOVOZYMES A/S/S (0.00%), BioNTech SE (0.00%), argenx SE - (0.00%), Qiagen NV (1.95%), and BIO-TECHNE Corp (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications Inc ($5.17 billion), Aon PLC ($3.57 billion), ViacomCBS Inc. ($3.01 billion), Clorox Co ($2.91 billion), Charles Schwab Co. ($2.80 billion), Mercadolibre Inc ($2.33 billion), Analog Devices, Inc. ($2.14 billion), Kroger Co ($1.99 billion), Moderna Inc ($1.96 billion), and Simon Property Group Inc ($1.80 billion). View all of the most shorted stocks.

What does it mean to sell short Gene Biotherapeutics stock?

Short selling CRXM is an investing strategy that aims to generate trading profit from Gene Biotherapeutics as its price is falling. Gene Biotherapeutics' stock is trading down $0.01 today. To short Gene Biotherapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Gene Biotherapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Gene Biotherapeutics?

A short squeeze for Gene Biotherapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRXM, which in turn drives the price of the stock up even further.

How often is Gene Biotherapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRXM, twice per month. The most recent reporting period available is September, 15 2020.


This page was last updated on 9/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.